VERU

VERU

USD

Veru Inc. Common Stock

$2.650+0.070 (2.713%)

实时价格

Healthcare
生物技术
美国

价格图表

Loading Chart...

关键指标

市场指标
公司基本面
交易统计

市场指标

开盘价

$2.580

最高价

$2.650

最低价

$2.580

成交量

0.18M

公司基本面

市值

42.5M

所属行业

生物技术

国家/地区

United States

交易统计

平均成交量

0.18M

交易所

NCM

货币

USD

52周价格范围

最低价 $2.42当前价 $2.650最高价 $14.2

AI分析报告

最后更新: 2025年11月10日
由AI生成数据来源: Yahoo Finance, Bloomberg, SEC

VERU Stock Analysis: Veru Inc. Navigates Volatility Amid Fundamental Challenges

Market Snapshot

Current Price: $2.61 (as of 2025-11-10) 52-Week Range: $2.42 - $14.20 Market Cap: $41.89M | P/E Ratio: -9.00 Recent Volatility: Sharp decline from $4.43 (Oct 20) to $2.61, with erratic volume patterns


Recent Performance: Turbulent Descent

Veru’s stock has been in a clear downtrend since mid-October, shedding 41% from its October peak. Key observations:

  • Public Offering Impact: The $25M offering on Oct 30 likely triggered selling pressure, with shares dropping 12% the following day.
  • Volume Anomalies: Unusually high trading volume on Oct 30 ($765,700) and Nov 3 ($489,500) suggests panic selling or institutional exits.
  • Support Zone: Recent closes near $2.52-$2.58 align with its 52-week low, indicating this range may act as temporary support.

Technical Signals: Mixed Messages

  • Bullish DMI: +DI (15.4) > -DI (14.1) with ADX at 19.0 implies a weak uptrend could form if buyers step in.
  • Volume Surge: 1.9x average volume on Nov 10 hints at renewed interest, but this could reflect short-term positioning rather than sustainable demand.
  • MACD Death Cross: Bearish momentum confirmed as MACD (0.0119) fell below signal line (0.0162) despite AI’s upward projections.

Fundamentals: Value Trap or Hidden Potential?

  • Contradictory Valuation: While the P/E (-9.00) appears broken due to negative earnings, the recommendation claims it’s “0.4x industry average” (likely referencing EBITDA multiples or forward estimates). Proceed with skepticism.
  • **High-Risk

相关新闻

GlobeNewswire

Veru to Present Two Abstracts at ObesityWeek 2025

MIAMI, FL, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ:VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory

查看更多
Veru to Present Two Abstracts at ObesityWeek 2025
GlobeNewswire

Veru Announces Pricing of $25 Million Public Offering

MIAMI, FL, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ:VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory

查看更多
Veru Announces Pricing of $25 Million Public Offering

AI预测Beta

AI建议

看涨

更新于: 2025年11月10日 14:42

看跌中性看涨

58.4% 置信度

风险与交易

风险等级3/5
中风险
适合于
价值
交易指南

入场点

$2.52

止盈点

$2.61

止损点

$2.30

关键因素

PDI 15.4高于MDI 14.1,且ADX 19.0,表明看涨趋势
交易量是平均值的1.9倍(3,174),表明市场参与度增加
MACD 0.0119低于信号线0.0162,表明看跌交叉

保持更新

设置价格提醒,获取AI分析更新和实时市场新闻。